TELADOC HEALTH INC (TDOC)
US87918A1051 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.10B | 1.12B | 918.00M | 893.00M | 733.00M | |||
| Marketable Securities | N/A | N/A | 0.00 | 3.00M | 53.00M | |||
| Receivables | 227.85M | 230.06M | 236.00M | 169.00M | 169.00M | |||
| Inventories | 32.27M | 29.51M | 56.00M | 73.00M | 56.00M | |||
| Other Current Assets | 128.21M | 105.80M | 105.00M | 87.00M | 47.00M | |||
| Total Current Assets | 1.49B | 1.49B | 1.31B | 1.23B | 1.06B | |||
| Non-Current Assets | ||||||||
| PPE Net | 67.06M | 72.09M | 71.00M | 74.00M | 75.00M | |||
| Goodwill | 1.07B | 1.07B | 1.07B | 14.50B | 14.58B | |||
| Intangibles | 1.61B | 1.68B | 1.84B | 1.91B | 2.02B | |||
| Other Non-Current Assets | 80.01M | 80.26M | 49.00M | 21.00M | 18.00M | |||
| Total Non-Current Assets | 2.83B | 2.90B | 3.03B | 16.51B | 16.70B | |||
| TOTAL ASSETS | 4.32B | 4.39B | 4.34B | 17.73B | 17.75B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 11.00M | 13.00M | 56.00M | |||
| Accrued Expenses | 196.09M | 238.92M | 193.00M | 162.00M | 156.00M | |||
| Accounts Payable | 37.67M | 43.64M | 48.00M | 47.00M | 46.00M | |||
| Other Current Liabilities | 155.08M | 138.06M | 147.00M | 108.00M | 75.00M | |||
| Total Current Liabilities | 388.84M | 420.62M | 400.00M | 331.00M | 333.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.54B | 1.54B | 1.54B | 1.24B | 1.39B | |||
| Deferred Taxes/Income | 47.47M | 49.45M | 51.00M | 76.00M | 102.00M | |||
| Other Non-Current Liabilities | 56.00M | 57.54M | 44.00M | 47.00M | 47.00M | |||
| Total Non-Current Liabilities | 1.64B | 1.65B | 1.64B | 1.36B | 1.54B | |||
| TOTAL LIABILITIES | 2.03B | 2.07B | 2.04B | 1.69B | 1.87B | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -15.31B | -15.23B | -15.01B | -1.42B | -993.00M | |||
| Additional Paid In Capital | 17.64B | 17.59B | 17.36B | 17.47B | 16.86B | |||
| Common Shares | 169.00K | 167.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -38.63M | -36.99M | -43.00M | -6.00M | 19.00M | |||
| Shares Outstanding | 169.31M | 166.66M | 163.00M | 160.00M | 150.00M | |||
| Tangible Book Value per Share | -2.35 | -2.55 | -3.69 | -2.30 | -4.79 | |||
| Total Shareholders' Equity | 2.29B | 2.33B | 2.31B | 16.05B | 15.88B | |||
| TOTAL LIABILITIES AND EQUITY | 4.32B | 4.39B | 4.34B | 17.73B | 17.75B | |||
| Statistics | ||||||||
| Debt/Equity | 0.67 | 0.66 | 0.67 | 0.08 | 0.09 | |||
| Current Ratio | 3.82 | 3.54 | 3.29 | 3.70 | 3.18 | |||
| Return On Assets (ROA) | -5.39% | -5.02% | -314.37% | -2.42% | -2.73% | |||
| Return On Equity (ROE) | -10.18% | -9.47% | -591.83% | -2.67% | -3.05% | |||
All data in USD